Conversely, masculinizing hormone therapy appears to induce subclinical kidney stress, as evidenced by elevated tubular injury biomarkers such as urine YKL-40 and plasma TNFR-1, without significant changes in mGFR or ERPF. Here, CHI3L1 is linked to psychosocial stress measurement.